The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study
Purpose: The study aimed to access the impact of related factors on the long-term survival of patients with B-cell acute lymphoblastic leukemia (B-ALL) by analyzing clinical characteristics of B-ALL patients, and observed the significance of dynamic measurable residual disease (MRD) assessment for t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2415589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850061200459563008 |
|---|---|
| author | Yongyu Chen Rongrong Liu Jing Li |
| author_facet | Yongyu Chen Rongrong Liu Jing Li |
| author_sort | Yongyu Chen |
| collection | DOAJ |
| description | Purpose: The study aimed to access the impact of related factors on the long-term survival of patients with B-cell acute lymphoblastic leukemia (B-ALL) by analyzing clinical characteristics of B-ALL patients, and observed the significance of dynamic measurable residual disease (MRD) assessment for the prognosis and treatment selection of B-ALL patients, aiming to deepen the understanding of the disease and improve the survival prognosis of B-ALL patients.Methods: The clinical characteristics of 65 patients with B-ALL were collected to calculate the median overall survival (OS) and median disease-free survival (PFS), and to evaluate the significance of survival analysis guided by dynamic MRD assessment.Results: The survival analysis based on dynamic MRD assessment suggested that B-ALL patients who maintained MRD negative status during dynamic assessment after induction chemotherapy had better survival outcomes in the comparison of progression-free survival between subgroups, with statistically significant differences (P = 0.0002 (HR: 0.26, 95% CI: 0.13-0.51)). High-risk B-ALL patients who maintained negative MRD status during dynamic assessment after induction chemotherapy had longer median progression – free survival, and the survival difference between subgroups was statistically significant (P = 0.0016 (HR: 0.28, 95% CI: 0.09-0.48)).Conclusion: Dynamic MRD assessment had significant clinical value: maintaining negative MRD status during dynamic assessment can improve the prognosis and survival of B-ALL patients; dynamic MRD assessment after induction chemotherapy can help guide subsequent treatment, which could provide reference for the advancement of future treatment strategies. |
| format | Article |
| id | doaj-art-e677d82faab24fd183a226c16496e12c |
| institution | DOAJ |
| issn | 1607-8454 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Hematology |
| spelling | doaj-art-e677d82faab24fd183a226c16496e12c2025-08-20T02:50:19ZengTaylor & Francis GroupHematology1607-84542024-12-0129110.1080/16078454.2024.2415589The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective studyYongyu Chen0Rongrong Liu1Jing Li2Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of ChinaDepartment of Hematology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of ChinaDepartment of Hematology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of ChinaPurpose: The study aimed to access the impact of related factors on the long-term survival of patients with B-cell acute lymphoblastic leukemia (B-ALL) by analyzing clinical characteristics of B-ALL patients, and observed the significance of dynamic measurable residual disease (MRD) assessment for the prognosis and treatment selection of B-ALL patients, aiming to deepen the understanding of the disease and improve the survival prognosis of B-ALL patients.Methods: The clinical characteristics of 65 patients with B-ALL were collected to calculate the median overall survival (OS) and median disease-free survival (PFS), and to evaluate the significance of survival analysis guided by dynamic MRD assessment.Results: The survival analysis based on dynamic MRD assessment suggested that B-ALL patients who maintained MRD negative status during dynamic assessment after induction chemotherapy had better survival outcomes in the comparison of progression-free survival between subgroups, with statistically significant differences (P = 0.0002 (HR: 0.26, 95% CI: 0.13-0.51)). High-risk B-ALL patients who maintained negative MRD status during dynamic assessment after induction chemotherapy had longer median progression – free survival, and the survival difference between subgroups was statistically significant (P = 0.0016 (HR: 0.28, 95% CI: 0.09-0.48)).Conclusion: Dynamic MRD assessment had significant clinical value: maintaining negative MRD status during dynamic assessment can improve the prognosis and survival of B-ALL patients; dynamic MRD assessment after induction chemotherapy can help guide subsequent treatment, which could provide reference for the advancement of future treatment strategies.https://www.tandfonline.com/doi/10.1080/16078454.2024.2415589Acute lymphoblastic leukemiameasurable residual diseasehematopoietic cell transplantationclinical hematologytherapy |
| spellingShingle | Yongyu Chen Rongrong Liu Jing Li The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study Hematology Acute lymphoblastic leukemia measurable residual disease hematopoietic cell transplantation clinical hematology therapy |
| title | The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study |
| title_full | The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study |
| title_fullStr | The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study |
| title_full_unstemmed | The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study |
| title_short | The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study |
| title_sort | significance of mrd based strategy by dynamic assessment to guide treatment decisions in b all the enlightenment provided by demonstrating survival differences in the retrospective study |
| topic | Acute lymphoblastic leukemia measurable residual disease hematopoietic cell transplantation clinical hematology therapy |
| url | https://www.tandfonline.com/doi/10.1080/16078454.2024.2415589 |
| work_keys_str_mv | AT yongyuchen thesignificanceofmrdbasedstrategybydynamicassessmenttoguidetreatmentdecisionsinballtheenlightenmentprovidedbydemonstratingsurvivaldifferencesintheretrospectivestudy AT rongrongliu thesignificanceofmrdbasedstrategybydynamicassessmenttoguidetreatmentdecisionsinballtheenlightenmentprovidedbydemonstratingsurvivaldifferencesintheretrospectivestudy AT jingli thesignificanceofmrdbasedstrategybydynamicassessmenttoguidetreatmentdecisionsinballtheenlightenmentprovidedbydemonstratingsurvivaldifferencesintheretrospectivestudy AT yongyuchen significanceofmrdbasedstrategybydynamicassessmenttoguidetreatmentdecisionsinballtheenlightenmentprovidedbydemonstratingsurvivaldifferencesintheretrospectivestudy AT rongrongliu significanceofmrdbasedstrategybydynamicassessmenttoguidetreatmentdecisionsinballtheenlightenmentprovidedbydemonstratingsurvivaldifferencesintheretrospectivestudy AT jingli significanceofmrdbasedstrategybydynamicassessmenttoguidetreatmentdecisionsinballtheenlightenmentprovidedbydemonstratingsurvivaldifferencesintheretrospectivestudy |